breast-implant associated anaplastic large cell lymphoma (BIA-ALCL)

The FDA has requested the recall of Allergan’s Biocell textured breast implants and tissue expanders as a result of the increased risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) with these devices. Read more


Health Canada will be updating its safety review of breast implants after it reported an increase in the amount of cases linked to a form of cancer. Read more

North America

French regulator Agence Nationale de Sécurité du Médicament (ANSM) has announced it will hold evidence gathering hearings following the Implant Files Scandal, according to the International Consortium of Investigative Journalists. Read more